CAS 1206170-62-8

Formula: C17H20N6O

InChI: InChI=1S/C17H20N6O/c1-17(2,3)23-16-12(9-18)13(19)8-14(22-16)21-11-6-4-10(5-7-11)15(20)24/h4-8H,1-3H3,(H2,20,24)(H4,19,21,22,23)

InChI key: XDEFNAWAKYQBQY-UHFFFAOYSA-N

SMILES: CC(C)(C)NC1=C(C(=CC(=N1)NC2=CC=C(C=C2)C(=O)N)N)C#N

4-[[4-Amino-5-cyano-6-[(1,1-dimethylethyl)amino]-2-pyridinyl]amino]benzamide

CAS: 1206170-62-8

4-[[4-Amino-5-cyano-6-[(1,1-dimethylethyl)amino]-2-pyridinyl]amino]benzamide

Formula: C₁₇H₂₀N₆O

Purity: ≥99%

Molecular weight: 324.38

Ref: 54-OR1115953

4-[[4-Amino-5-cyano-6-[(1,1-dimethylethyl)amino]-2-pyridinyl]amino]benzamide

CAS: 1206170-62-8

Purity: 99%

Ref: IN-DA01ENNQ

TC-Mps1-12

CAS: 1206170-62-8

TC-Mps1-12 is a drug target for skin cancer and bladder cancer. TC-Mps1-12 inhibits the tyrosine kinase activity of the epidermal growth factor receptor (EGFR) and its downstream signalling cascades, which are involved in cell proliferation. This drug has been shown to be effective in decreasing tumour size in mice with skin cancer. TC-Mps1-12 also inhibits the EGFR downstream signalling pathways in bladder cancer cells, leading to decreased production of inflammatory cytokines and increased apoptosis.

Formula: C₁₇H₂₀N₆O

Purity: Min. 95%

Molecular weight: 324.38 g/mol

Ref: 3D-GYB17062

TC-Mps1-12

CAS: 1206170-62-8

TC-Mps1-12 is an effective and selective inhibitor of monopolar spindle 1 (IC50: 6.4 nM) .

Formula: C₁₇H₂₀N₆O

Purity: 98%

Color and Shape: Solid

Molecular weight: 324.38

Ref: TM-T17007